Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kentuckiana Cancer Institute
A phase I/II dose escalating study to determine the maximum tolerated dose of docetaxel when given with Irinotecan and Carboplatin for the treatment of inoperable lung cancer.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years or older unresectable lung cancer measurable or evaluable lesions Karnofsky PS greater than or equal to 60%
